dc.contributor.author | Lee, Daniel J. | |
dc.contributor.author | Barocas, Daniel A. | |
dc.contributor.author | Demirdag, Cetin | |
dc.contributor.author | Keegan, Kirk A. | |
dc.contributor.author | Joyce, Daniel D. | |
dc.date.accessioned | 2021-12-10T11:13:06Z | |
dc.date.available | 2021-12-10T11:13:06Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | Joyce D. D. , Lee D. J. , Demirdag C., Keegan K. A. , Barocas D. A. , "Predictors of Compliance with Muscle Invasive Bladder Cancer Quality Measures and its Effect on Survival Outcomes", UROLOGY PRACTICE, cilt.8, sa.1, ss.65-70, 2021 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_6f386f87-3a3e-43c1-95db-324743ae5648 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/171444 | |
dc.identifier.uri | https://doi.org/10.1097/upj.0000000000000175 | |
dc.description.abstract | Introduction: To assess and improve quality of care, the Commission on Cancer developed 3 evidence-based quality measures for the treatment of muscle invasive bladder cancer. We sought to assess performance of these measures prior to their implementation, whether compliance was associated with survival and whether patient factors influenced compliance. | |
dc.language.iso | eng | |
dc.subject | Nefroloji | |
dc.subject | Nephrology | |
dc.subject | Urology | |
dc.subject | Health Sciences | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ÜROLOJİ VE NEFROLOJİ | |
dc.title | Predictors of Compliance with Muscle Invasive Bladder Cancer Quality Measures and its Effect on Survival Outcomes | |
dc.type | Makale | |
dc.relation.journal | UROLOGY PRACTICE | |
dc.contributor.department | Vanderbilt University , , | |
dc.identifier.volume | 8 | |
dc.identifier.issue | 1 | |
dc.identifier.startpage | 65 | |
dc.identifier.endpage | 70 | |
dc.contributor.firstauthorID | 2645752 | |